u/StockyJ122 · 3h agono track record yet
Citi predicts 410% rally for BMEA (currently under $1.50)
Citi analyst rates BMEA a Buy with a $7 price target (410% upside from $1.37), driven by anticipated positive Phase 1 weight-loss data for BMF-650, an oral GLP-1 candidate with promising early efficacy comparable to or better than competitors.